If you cannot see this email please follow this link.
Newsletter Regulatory Affairs
Your monthly regulatory affairs update
{Anrede}

Welcome to the September 2026 edition of our Regulatory Affairs Newsletter.

With this issue, we share an overview of the most relevant regulatory developments from recent weeks. You will also find a summary of the latest Online Pharma Forum webcast on the use of AI in Medical Affairs.

If you have any requests or suggestions, please feel free to contact us. We look forward to hearing from you!

Editorial
News from ICH
News from European Commission
News from EMA
News from CMDh
News for Veterinary medicines
News from BfArM/PEI
Global and general European Regulatory News
Monthly reports
Editorial

As part of the Online Pharma Forum webcast, Lisa-Cathrin Uebel, LL.M., Senior Legal Counsel at STADA Arzneimittel AG, gave a presentation on 12 August 2026 on the topic "Use of AI in Medical Affairs - what is legally permissible?". […]
... Read more


News from ICH
The ICH and International Society of Pharmacovigilance (ISoP) have signed a Memorandum of Understanding (MoU) to advance global awareness and adoption of harmonised pharmacovigilance requirements.
Details


ICH released the MedDRA Version 29.1 in English. All 26 language translations will be available on 15 September 2026.
Details


PharmaFORUM Webcast International - More information >>

News from European Commission
The European Commission has updated its guidance on the submission of early information for joint clinical assessment (JCA) of medicinal products.
Details


HaDEA has published an EU4Health call for tenders to support the development of and access to technologies that can prolong the shelf life of active pharmaceutical ingredients (APIs) stored in bulk and produce finished dose forms rapidly. The call is open until 29 September 2026.
Details

The further training "APIs in the dossier: Quality data, e-submission, global regulatory strategy" (in English) on 28-29 September 2026, includes updates on (Draft) ICH Q1, ICH M4Q(R2)), ICH Q12, Reliance, AI, etc.
Details



HaDEA has published an EU4Health call for tenders to advance the EU FAB+ PPE pilot, an initiative designed to strengthen the EU′s capacity to ensure rapid availability of personal protective equipment (PPE). The call is open until 15 October 2026.
Details


News from EMA
EMA has published guidance on the revised pre-submission interactions model (PSI).
Details


The European medicines regulatory network (EMRN) has published a draft on a new data standards framework. Public consultation is open until 18 September 2026.
Details

Data management will be newly harmonised by the finalisation of the “EU GMP Revision: Chapter 4, Annex 11, Annex 22” which is expected by the end of 2026.
During the eponymous online course on 11 November 2026 (in English) you will learn what the changes to the guideline mean for your practice.
Details



The EMA published a revised template and supplementary guidance on the “Shortage Prevention Plan (SPP)”.
Details

During the online course “Lieferantenqualifizierung: GMP-Anforderungen umsetzen“ (in German) on 11 December 2026 you will among other receive an update on the revision of the EU GMP Guidelines (Chapter 4, Annexes 11 and 22) and tips on the safe use of AI and cloud technologies.
Details



Online Pharma FORUM: Weiterbildung immer und überall via Internet-Liveschaltung! - Jetzt Demopräsentation ansehen! >>

News from CMDh
CMDh has updated the guidance published by Member States on the implementation of the Falsified Medicines Directive.
Details


News for Veterinary medicines
The FORUM Institute is offering a seminar on "QPPV & PSMF in der Vet-Pharmakovigilanz" on 14 December 2026 (in German).
Details



News from BfArM/PEI
Invitations were sent out for the public event "In dialogue with BfArM and PEI: CTR and more", to be held on 16 September 2026.
Details


Global and general European Regulatory News
Mexico’s Cofepris has established a simplified procedure for registering medicines previously assessed and approved by Brazil’s Anvisa.
Details

What do these developments mean for your regulatory strategy? Our interactive online seminar examines real cases across six Latin American markets with local experts from Brazil and Peru.
Details



The FDA announced the availability of a new draft guidance document entitled ‘Container Closure Systems for Human Drugs and Biological Products’.
Details

One aspect of the “Hot topics and current challenges” lecture of the seminar “CMC dossier requirements: FDA vs EU” (in English) on 6 October 2026 will be the FDA draft guidance document on container closure systems.
Details



The International Pharmaceutical Excipients Council Europe (IPEC) has published the updated Version 3 of its ‘Excipient Stability Guide for Pharmaceutical Excipients’ on its website.
Details

A general overview on current global stability requirements will be given during the online seminar “Global stability: From regulatory framework to practical application” (in English) on 26 November 2026.
Details



The UK Government has tabled three amendments to the Health Bill concerning information sharing, updates to medicines and medical devices legislation, and the potential development of a future medical device licensing regime.
Details

Monthly reports
PRAC
Details

CHMP
Details

CMDh
Details

CVMP
Details


Kind regards,

Jean-Marie Bayhurst
Your contact for
Regulatory Affairs (Human)
+49 6221 500-685
Dr C. Michaela Gottwald
Your contact for
Regulatory Affairs (Veterinary)
+49 6221 500-610
Dr Birgit Wessels
Your contact for
CMC
+49 6221 500-652


Verena Planitz
Your contact for
Global Regulatory Affairs
+49 6221 500-655

TO UNSUBSCRIBE:
If you do not want to receive this information in future, you can unsubscribe here!
FORUM ⋅ Institut für Management GmbH ⋅ Vangerowstr. 18 ⋅ 69115 Heidelberg ⋅ Germany
Fon +49 6221 500-500 ⋅ Fax +49 6221 500-555 ⋅ service@forum-institut.de www.forum-institut.de/en
Copyright 2026 FORUM ⋅ Institut für Management GmbH
Imprint, privacy policy, terms and conditions

We guarantee the highest quality with ISO 9001 and ISO 21001 certifications.
Nachhaltigkeit